Ensign Peak Advisors, Inc Charles River Laboratories International, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $51.2 Billion
  • Q1 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 14,699 shares of CRL stock, worth $2.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,699
Previous 16,122 8.83%
Holding current value
$2.21 Million
Previous $2.98 Million 25.67%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$150.52 - $190.14 $214,189 - $270,569
-1,423 Reduced 8.83%
14,699 $2.21 Million
Q3 2024

Nov 14, 2024
BUY
$187.96 - $245.29 $75,184 - $98,116
400 Added 2.54%
16,122 $3.18 Million
Q1 2024

May 14, 2024
SELL
$203.52 - $273.43 $28,696 - $38,553
-141 Reduced 0.89%
15,722 $4.26 Million
Q4 2023

Feb 14, 2024
SELL
$164.52 - $238.84 $699,045 - $1.01 Million
-4,249 Reduced 21.13%
15,863 $3.75 Million
Q3 2023

Nov 13, 2023
SELL
$194.44 - $217.61 $36,554 - $40,910
-188 Reduced 0.93%
20,112 $3.94 Million
Q2 2023

Aug 14, 2023
BUY
$183.71 - $210.25 $91,855 - $105,125
500 Added 2.53%
20,300 $4.27 Million
Q1 2023

May 15, 2023
SELL
$191.89 - $259.92 $883,461 - $1.2 Million
-4,604 Reduced 18.87%
19,800 $4 Million
Q4 2022

Feb 13, 2023
BUY
$197.11 - $250.07 $1.79 Million - $2.27 Million
9,091 Added 59.37%
24,404 $5.32 Million
Q3 2022

Nov 14, 2022
SELL
$182.44 - $250.54 $575,415 - $790,203
-3,154 Reduced 17.08%
15,313 $3.01 Million
Q2 2022

Aug 12, 2022
BUY
$204.13 - $302.4 $30,619 - $45,360
150 Added 0.82%
18,467 $3.95 Million
Q1 2022

May 16, 2022
SELL
$255.51 - $362.11 $555,734 - $787,589
-2,175 Reduced 10.61%
18,317 $5.2 Million
Q4 2021

Feb 11, 2022
BUY
$351.38 - $448.68 $4.78 Million - $6.11 Million
13,615 Added 197.98%
20,492 $7.72 Million
Q3 2021

Nov 12, 2021
BUY
$372.64 - $458.3 $1.3 Million - $1.6 Million
3,487 Added 102.86%
6,877 $2.84 Million
Q2 2021

Aug 13, 2021
SELL
$294.17 - $371.65 $13.4 Million - $16.9 Million
-45,519 Reduced 93.07%
3,390 $1.25 Million
Q1 2021

May 12, 2021
SELL
$249.67 - $299.48 $53,179 - $63,789
-213 Reduced 0.43%
48,909 $14.2 Million
Q4 2020

Feb 12, 2021
SELL
$222.0 - $252.62 $237,984 - $270,808
-1,072 Reduced 2.14%
49,122 $12.3 Million
Q3 2020

Nov 12, 2020
BUY
$175.56 - $226.45 $919,934 - $1.19 Million
5,240 Added 11.66%
50,194 $11.4 Million
Q2 2020

Aug 12, 2020
BUY
$118.84 - $189.72 $573,997 - $916,347
4,830 Added 12.04%
44,954 $7.84 Million
Q1 2020

May 11, 2020
SELL
$98.9 - $178.34 $240,327 - $433,366
-2,430 Reduced 5.71%
40,124 $5.06 Million
Q4 2019

Feb 14, 2020
BUY
$126.05 - $152.76 $5.36 Million - $6.5 Million
42,554 New
42,554 $6.5 Million

Others Institutions Holding CRL

# of Institutions
613
Shares Held
54.8M
Call Options Held
722K
Put Options Held
847K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.65B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email